Zoetis (ZTS) falls 0.40% for January 14

Equities Staff  |

Zoetis Inc - Class A (NYSE: ZTS), a Parsippany, New Jersey, company, fell to close at $206.18 Friday after losing $0.82 (0.40%) on volume of 2,209,116 shares. The stock ranged from a high of $207.40 to a low of $203.41 while Zoetis’s market cap now stands at $97,549,081,980.

Zoetis currently has roughly 9200 employees.

About Zoetis Inc - Class A

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.

Visit Zoetis Inc - Class A’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Zoetis Inc - Class A and to follow the company’s latest updates, you can visit the company’s profile page here: Zoetis Inc - Class A’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Commodities Post Strongest Gains in Over a Decade
Charlie Munger Doubles Down on Alibaba While the Fed Signals Tightening
Commodities — Assessing 2021 and Forecasting 2022



Market Movers

Sponsored Financial Content